Article Details

Oxurion Announces New Data on THR-149 Phase 2 Clinical - GlobeNewswire

Retrieved on: 2022-02-14 07:01:35

Tags for this article:

Click the tags to see associated articles and topics

Oxurion Announces New Data on THR-149 Phase 2 Clinical - GlobeNewswire. View article details on hiswai:

Excerpt

Post-hoc analysis reveals >9 letter gain in mean BCVA that was maintained for the remaining four months of the trial after the last THR-149 ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up